Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy-Reference-Cited by-同舟云学术

Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy

Published:2015-01 Issue:1 Volume:21 Page:55-59
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Eapen Mary,Logan Brent R.,Appelbaum Fredrick R.,Antin Joseph H.,Anasetti Claudio,Couriel Daniel R.,Chen Junfang,Maziarz Richard T.,McCarthy Philip L.,Nakamura Ryotaro,Ratanatharathorn Voravit,Vij Ravi,Champlin Richard E.

Funder

National Cancer Institute, the National Heart Lung and Blood Institute

National Institute of Allergy and Infectious Diseases

Health Resources and Services Administration

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference12 articles.

1. Peripheral blood stem cells versus bone marrow from unrelated donors;Anasetti;N Engl J Med,2012

2. Long-term outcome of patients given transplants of mobilized blood or marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation;Schmitz;Blood,2006

3. Long-term outcomes and late effects in patients transplanted with mobilized blood or bone marrow: a randomised trial;Friedrichs;Lancet Oncol,2010

4. Defining the intensity of conditioning regimens: working definitions;Bacigalupo;Biol Blood Marrow Transplant,2009

5. Chronic graft-versus-host disease syndrome in man: a long-term clinicopathophysiologic study 20 Seattle patient;Shulman;Am J Med,1980

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Treosulfan- or Busulfan-Based Conditioning in Pediatric Patients with Acute Leukemia or Myelodysplastic Syndrome: Results of an Associazione Italiana Ematologia Oncologia Pediatrica Retrospective Study;Transplantation and Cellular Therapy;2024-04

2. Introduction on Stem Cell Therapy and Regeneration;Comprehensive Hematology and Stem Cell Research;2024

3. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates;Cytotherapy;2023-04

4. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland;International Journal of Cancer;2023-02-21

5. Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation;Journal of Adolescent and Young Adult Oncology;2023-02-01